MTHERA PHARMA

MThera Pharma Co., Ltd. is a biopharmaceutical company focused on developing novel multi-component/multi-target driven, disease-modifying therapies for chronic incurable diseases. MThera has established platform technology, SyMthomics consists of MThera-CODA system (AI based in silico system), the most cutting-edge multi-omics integration technology, systems biology and bioinformatics. MThera has set up standardization technology & advanced CMC technology for raw materials, drug substances and drug products to meet the US FDA requirement for therapeutic consistency and totality of the evidence. MThera is pioneering first-in-class botanical drug products to deal with diverse etiology and treat chronic incurable diseases like Parkinson's disease and Inflammatory bowel disease.